The endpoints for which ROI were least representative of whole tumor were percent of CD8+/Ki67+ cells in the stroma (PCC 0.65), and PD-1+/CD8+ cell density in the epithelial compartment (PCC 0.70). This evidence concerns the gene RPL17 and neoplasm.